Kirk K Lin
Affiliation: University of California
- Durability of infliximab dose intensification in Crohn's diseaseKirk K Lin
Division of Gastroenterology, Department of Internal Medicine, University of California at San Francisco, San Francisco, CA, USA
Dig Dis Sci 57:1013-9. 2012..Dose intensification is a common approach to treat Crohn's disease (CD) patients who lose response to infliximab maintenance therapy. Few studies have reported upon its long-term efficacy or predictors of response...